• What’s Wrong With Herbal Supplements?

What’s Wrong With Herbal Supplements?

Herbal supplements, used by many people for weight loss and bodybuilding purposes but also to improve well-being and reduce symptoms of chronic diseases, have recently come under investigation because of uncertainty about their contents, safety, and efficacy. On February 3, the New York Times wrote that the New York State attorney general’s office accused 4 major retailers of selling

Read more

What Can Relieve Symptoms of Functional Dyspepsia?

Buspirone, an agonist of the serotonin receptor 5-HT1A, relaxes the proximal stomach to reduce symptoms of functional dyspepsia and increase gastric accommodation, according to trial results presented in the November issue of Clinical Gastroenterology and Hepatology. Functional dyspepsia is a common gastrointestinal disorder. It is characterized by early satiation, postprandial

Read more

Can Antioxidants Reduce Pain from Chronic Pancreatitis?

A randomized, placebo-controlled trial published in the September issue of Gastroenterology found that antioxidants do not reduce pain or improve quality of life in patients with chronic pancreatitis—at least for middle-aged patients with alcohol- or smoking-related disease. Chronic pancreatitis is characterized by inflammation of the pancreas, with loss of normal

Read more

Treating Rumination and Supragastric Belching

Baclofen is an effective treatment for patients with rumination or supragastric belching/aerophagia, according to the April issue of Clinical Gastroenterology and Hepatology. Rumination syndrome is characterized by the effortless, often repetitive regurgitation of recently ingested food into the mouth; it results from contraction of the abdominal muscles and a subsequent

Read more

Do Stents Prevent Pancreatitis After ERCP?

Pancreatic duct stents reduce the incidence of pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP), according to a study published in the October issue of Clinical Gastroenterology and Hepatology. Pancreatitis is the most common and potentially serious complication following ERCP, occurring in up to 9% of patients that receive this procedure and

Read more

New Treatment for IBS

LX1031, a drug that inhibits serotonin production, relieves symptoms and increases stool consistency in patients with nonconstipating irritable bowel syndrome (IBS), according to a study by Philip Brown et al. in the August issue of Gastroenterology. Serotonin (also called 5-hydroxytryptamine or 5-HT) is a neurotransmitter that controls mood and cognition, as

Read more